Comparing plain old balloon and drug-coated balloon supported bare metal stents in the treatment of femoral-popliteal TASC D lesions
10.3760/cma.j.cn113855-20210124-00053
- VernacularTitle:药物涂层球囊联合支架植入与普通球囊联合支架植入治疗股腘动脉TASC D级病变的疗效比较
- Author:
Yue LIN
1
;
Xiang HONG
;
Daqiao GUO
;
Zhenyu SHI
;
Weifeng LU
;
Shichai HONG
;
Gang CHEN
;
Yulong HUANG
;
Yihui CHEN
;
Lixin WANG
;
Weiguo FU
Author Information
1. 复旦大学附属中山医院厦门医院血管外科，厦门 361015
- Keywords:
Arteriosclerosis;
Angioplasty;
Drug-coated balloon;
Femoropopliteal artery
- From:
Chinese Journal of General Surgery
2022;37(1):21-25
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To compare the efficacy between drug-coated balloon (DCB) combined with bare metal stenting (BMS) and plain old balloon angioplasty (POBA) with BMS placement in the treatment of femoral-popliteal TASC D lesions.Methods:According to the Trans-Atlantic Inter-Society Consensus (TASC) D grade femoral-popliteal lesions as the standard, we enrolled 115 cases (120 limbs) receiving DCB combined with BMS (group DCB, 37 limbs in 36 cases) and POBA combined with BMS (group POBA, 83 limbs in 79 cases) from Jan 2017 to Mar 2020 to observe patency rate, freedom from clinical-drived target lesion reintervention rate (FCD-TLR) and complications.Results:The mean follow-up time was 18.1 months and the average occlusion length was (29.1±6.5)mm. In group DCB vs group POBA, the primary patency rates at 3-month, 9-month, 1-year and 2-year were 89.2% vs. 86.7%, 86.4% vs. 76.9%, 66.8% vs. 70.9% and 63.1% vs. 56.9%, respectively ( P=0.73); FCD-TLRs were 100.0% vs. 95.1%, 94.3% vs. 82.3% , 78.5% vs. 80.6% and 74.1% vs. 68.9% ( P=0.69), respectively. Conclusion:The benefit of DCB combined with BMS over POBA combined with BMS in improving the early primary patency rate and reducing FCD-TLR was not definite.
